Zyprexa Papers

Zyprexa Papers Documents:

A Memorandum Final Judgment Order & Injunction 07504

A Texas lawsuit

ADA 1

ADA 2

ADA 3

ADA 4

ADA 5

ADA 6

ADA 7

ADA 8

ADA 9

ADA 11

ADA 12

ADA 13

ADA 14

ADA 15

ADA email

Adverse Effects 1998

AER RCTs

Alan and Charles

APA 2001 – the competition

Arbuck 1

Article in Lancet

Australia

Bandick talk

Beasley email 2

Beasley presentation

Berenson Zyprexa

Betting_the_farm

biol psych review

Bipolar 2000 A

Bipolar 2000

Bipolar 2002

Bipolar 2003

Bipolar APA 2002

Bipolar APA 2003

Bipolar disorder 2002 a

Bipolar Early

Bipolar Primary Care A & C

Bipolar Primary Care

Bipolar Strategy.ppt TM

Bipolar Tollefson 1997

Bipolar Weight

Blood Results

Blood Results 2

Brand 1.ppt TM

Brand 2001

Brand Architecture

Brand Council

Brand Decliners

Brand Leadership

Brand Promise 2000

Brand Promise and Weight

Brand Segmentation

Brand Segmentation 2

Brand Strategy 2003

Brand Strategy 2003 A

Breier Patients First

Case Reports

Casey Email

Casey Poster

Cavazzoni Lilly Diabetes Study

Challenge Dechallenge

Citrome Article

Core Beliefs

Diabetes 2000

Diabetes 2002

Diabetes and DKA

Diabetes and S.ppt TM

Diabetes and Schiz 2001 1

Diabetes Antipsychotic Study

Diabetes Antipsychotics USA 2001

Diabetes Crisis 2002

Diabetes Crisis 2002 FDA

Diabetes Crisis 2003 FDA

Diabetes Email

Diabetes Email 2

Diabetes Email 3

Diabetes Email 4

Diabetes Email 5

Diabetes for Reps 2002

Diabetes Globally 2000

Diabetes in Mental Illness – Koller

Diabetes Key Messages 2002

Diabetes Label 2002

Diabetes Positioning

Diabetes Reps 4

Diabetes Strategy 2001

Diabetes Strategy 2002

Diabetes Strategy 2003

Donna and Diabetes

Donna Diabetes

Donna FAOC Donna

Doraiswamy Letter

Early Development

Early HD

Elderly Psychosis

Email 1

Email 2

Email 3

Email 4

Email 7

Email 8

Email 9

Email 10

Email 11

Email 12

Email 15

Email 16

Email 17

Email 18

Email 19

Email 21

Email 22

Email 23

Email 25

Email 26

Email 27

Email 28

Email 29

Email Diabetes 4

Email Diabetes 6

Email FDA

Email Glucose

Email MGH Meeting

Email Primary Care

Email Primary Care 2

Email

Email24

Emotional Level

Endocrine Advisory Board

Endocrine Consult 2

Endocrinologists

Famous Slide

FAOC Donna

FDA 1

FDA 2 2003

FDA 3

FDA 7

FDA 9

FDA 10

FDA 12

FDA 13

FDA 17

FDA 18

FDA 20

FDA 21

FDA 24

FDA 26

FDA 27

FDA Canada Label

FDA CPMP

FDA CPMP 2

FDA CPMP 3

FDA CPMP 5

FDA Diabetes 2003

FDA EMEA

FDA European Label

FDA Katz Phone Call

FDA MCA

FDA PDAC Email

FDA Study

FDA Sweden

FDA TGA

FDA TGA 2

FDA Tollefson

FDA4

FDA5

FDA6

FDA25

FDA26

FDA27

Focus Group 1995

Focus Group 2002

Focus Group 2003

Focus Group Diabetes Newcomer

Framingham Heart

Glucose Reps

GPRD Antipsychotics and Diabetes 2001

HD for Reps 2001

HD Labelling 2003

HD Lit 2000

HD Literature 2001

HD Strategy 2

HD Strategy

HD Strategy 2001

HD Strategy 2001 A

HDL 2002

HDL for Reps

HDL Lit 1999

HDL Literature 2002

HDL Literature 2002 A

HDL Literature 2003

Healey Email

HGAJ Trial

HGAP Study

HGAP2

History Zyprexa Struther

Holt Article

Hyperglycemia 2001

Hyperglycemia Label 2003

Japan 1

Japan 2

Japan 3

Japan 4

Japan 5

Japan 6

Japan 7

Japan 8

Japan 9

Japan 10

Japan 11

Japan 12

Japan 13

Japan 14

Japan 15

Japan 16

Key Messages on Side Effects

Key Player

Lab Results 3

Lab Values

Labelling 2000

Labels Diabetes

Lindenmayer Trial 2002

Marketplace Plan Helen

Martha 1

Martha 2

Martha 3

Martha 4

Martha 5

Martha Docs

Mcneely Article

Media 2002

Media 2003

Media Diabetes 2000

Medwatch 1

Medwatch 2

Medwatch 3

Medwatch 4

Medwatch 5

Medwatch 6

Medwatch 7

Medwatch 8

Metabolic 2003

Metabolic 2003 A

Metabolic Risperdal et al

Metabolic Syndrome

MGH DKA

Nasrallah Anti Zyprexa

National Sales 2001

Nemeroff Dia

Newcomer 1 Diabetes

Newcomer 02-03-04

Newcomer 2

Newcomer 3

Newcomer 4

Newcomer 05-03-04

Newcomer 5

Newcomer 6

Newcomer 07-08-02

Newcomer 7

Newcomer 08-07-02 Rosack

Newcomer 8

Newcomer 09-08-02 Fear

Newcomer 9 Rosack

Newcomer 10

Newcomer 11

Newcomer 12

Newcomer 13

Newcomer 15-06-02

Newcomer 17-10-03 Rosack2

Newcomer 18-02-02 Comment on Talk

Newcomer 19-09-01 Diabetes

Newcomer 20-02-04 Good

Newcomer 20-06-02

Newcomer Talk 6

Off_Label_Primarycare

Off-Label Reps

Off-Label Strategy

Olanzapine and Weight 1999

Olanzapine Lifeplan

PCP Mood

Perceptions of Diabetes and AP

Physician Strategy and Weight

PI

PI 2

Primary Care 1

Primary Care 2 David

Primary Care 3 Off Label

Primary Care 4

Primary Care 5 1999

Primary Care 6 2000 Viva Zyprexa

Primary Care 2000

Primary Care 2001

Primary Care 2002

Primary Care and Weight – Own the Issue

Primary Care Backlash

Primary Care Launch 2000

Primary Care Launch

Primary Care Mood

Primary Care Mood and Diabetes

Primary Care Mood Patients

Primary Care Mood Patients 2

Primary Care Strategy 3

Primary_Care_Oppty

Product Plan 2001

Psych Segments.ppt TM

QT v Lipids

Regulatory History

Regulatory History 2

Rep Aggro

Safety Letter to Docs

Safety Policy 2002

Saunders Statement

Schiz Diabetes

Schiz Puerto Rico 1995

Schiz Weight 2003

Segmentation Email

Silverman on Antipsychotics

SPP Action Plan

Stahl Metabolic 1

Statement 1

Strategy 1995

Strategy 1996

Strategy 2003

Suicide et al Reports

Tennison Testy

Time of Onset

TMAP

Tracking Study

Tracking Study 2000

Turnbull Letter

Turnbull Letter 2

Turnbull Memo

Ventura Letter

Ventura Letter 1

Versus Risperdal 1998

Versus Risperdal 2001

Veterans Diabetes

Vets Study

Weight 2003 Issues Focus

Weight 2003

Weight 2004

Weight and Diabetes

Weight and Market

Weight and Olanzapine Draft Article

Weight Change 2000

Weight Gain 2000

Weight Gain Canada 2000

Weight Gain Rep Strategy Ireland

Weight Gain Strategy 1998

Weight HD

Weight Linguistics

Weight Lit 2003

Weight Literature 2000

Wilson Article

WSJ 1

Z Docs.xls TM

Zyprexa 1995

Zyprexa 2002

Zyprexa 2002 1

Zyprexa 2002 2

Zyprexa 2002 3

Zyprexa 2002 4

Zyprexa 2003

Zyprexa Approval Call

Zyprexa Business 2002

Zyprexa Confidential Order PO

Zyprexa For Reps 2003

Zyprexa Market 1995